CJC-1295 without DAC, also known as MOD GRF 1-29, is a synthetically modified analogue of growth hormone-releasing hormone (GHRH). Unlike its DAC-containing counterpart, this variant lacks the Drug Affinity Complex, resulting in a shorter half-life that more closely mimics the natural pulsatile release of growth hormone. This pharmacokinetic profile makes it a widely studied compound in research settings focused on endocrine signalling and somatotropic axis regulation.
In preclinical research, MOD GRF 1-29 has been investigated for its ability to stimulate pituitary somatotroph cells, promoting the endogenous release of growth hormone (GH) and subsequently increasing insulin-like growth factor 1 (IGF-1) levels. Researchers have explored its potential applications in models of GH deficiency, metabolic regulation, muscle tissue studies, and adipose tissue behaviour.
Specifications: Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂, Molecular Weight: 3367.9 g/mol, Purity: >98% (HPLC verified), CAS Number: 863288-34-0, Form: Lyophilised Powder.
Storage: Store lyophilised product at -20°C. Once reconstituted, store at 4°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Molecular Formula
C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight
3367.9 g/mol
Purity
>98%
CAS Number
863288-34-0
Form
Lyophilised Powder
Research Applications
Growth hormone secretion studies, IGF-1 modulation research, endocrine signalling, metabolic regulation, muscle tissue research, adipose tissue studies
For research purposes only. Not for human use.
Reviews
There are no reviews yet.